# Treatment of Insulin Resistance in Hypertensive, Obese Adolescents

> **NCT00185705** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 30 (estimated)

## Conditions studied

- Hypertension
- Insulin Resistance
- Dyslipidemia

## Interventions

- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT00185705
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Primary investigator moved to different university
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185705, "Treatment of Insulin Resistance in Hypertensive, Obese Adolescents". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00185705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*